Today's Top 20 Gastroenterology and Endoscopy Stories
-
Atlantic General Endoscopy Center, Novant Health & more: 3 GI practices in the news
Here are three practices with gastroenterology services making news: - 4/12/18 -
Ferring Pharmaceuticals, Custom Ultrasonics & more — 5 GI company key notes
Here are five updates on GI companies from the past week. - 4/11/18 -
PPIs not tied to 1st time strokes — 3 insights
Proton pump inhibitors do not increase the risk of first-time stroke in regular users, according to study published in Gastroenterology. - 4/11/18 -
5 things to know about Allergan Pharmaceuticals
Dublin, Ireland-based Allergan Pharmaceuticals is a global company focused on developing and commercializing branded drugs, devices and surgical solutions. - 4/11/18 -
FDA approves Custom Ultrasonics' automated endoscope reprocessor after previously suspending production — 5 insights
The FDA approved Custom Ultrasonics' 83 Plus Automated Endoscope Reprocessors for use in healthcare facilities to wash and disinfect flexible endoscopes, duodenoscopes and scope accessories between use. - 4/11/18 -
5 things to know about Interscope
Whitinsville, Mass.-based Interscope was founded to develop interventional endoscopic techniques that promote the shift to outpatient surgery. - 4/10/18 -
GI leader to know: Dr. William Wu of Eugene Gastroenterology Consultants
William Wu, MD, is a gastroenterologist at Eugene (Ore.) Gastroenterology Consultants. - 4/10/18 -
Atlantic General Endoscopy Center turns 10 — 4 insights
Berlin, Md.-based Atlantic General Endoscopy Center is celebrating its 10th anniversary, the Sussex Countian reports. - 4/10/18 -
4 things to know about the interstitium, a newly discovered organ
Researchers discovered what may be a new organ: a network of fluid-filled spaces in connective tissues all over the body known as the interstitium, Scientific American reports. - 4/9/18 -
The 3 pieces of tech that'll transform gastroenterology
The 2018 AGA Shark Tank featured five innovators presenting their new gastroenterology technologies to a panel of sharks including GI experts, a venture capitalist and a commercial payer among others at the 2018 AGA Tech Summit, March 21 to March 23 in Boston. - 4/9/18 -
GI leader to know: Dr. Michael Epstein of Digestive Disorders Associates
Michael Epstein, MD, is a gastroenterologist at Annapolis, Md.-based Digestive Disorders Associates. - 4/9/18 -
5 most read GI/endoscopy stories: April 2-6
Here are the five most popular gastroenterology and endoscopy stories for the week of April 2 to April 6, 2018. - 4/9/18 -
GI leader to know: Dr. Richard Panicco of Southwest Gastroenterology Associates
Richard Panicco, DO, is a gastroenterologist at Washington, Pa.-based Southwest Gastroenterology Associates. - 4/6/18 -
DNA link to IBS in women found — 5 insights into new research
Research out of Solna, Sweden-based Karolinska Institutet claims to have found a link to irritable bowel syndrome in certain DNA variants. - 4/6/18 -
Ferring Pharmaceuticals to acquire Rebiotix — 4 insights
Ferring Pharmaceuticals agreed to acquire Rebiotix for an unspecified sum. - 4/6/18 -
Drs. William Chey, Timothy Scherer & more: 4 GI physicians making headlines
Here are four gastroenterologists who made headlines this past week. - 4/6/18 -
Perrigo launches 1st store brand heartburn medication — 4 insights
Perrigo and Dexcel Pharma Technologies launched Omeprazole Delayed Release Orally Disintegrating Tablets, an over-the-counter medication to treat heartburn. - 4/6/18 -
10 cars gastroenterologists are most likely to drive
Gastroenterologists are most likely to drive Toyotas, according to the Medscape Gastroenterologist Lifestyle Report 2018: Personal Happiness vs Work Burnout. - 4/6/18 -
$25M Memorial Hermann Cypress Hospital expansion to include GI endoscopy suite: 3 things to know
Memorial Hermann Cypress (Texas) Hospital's recently approved $25 million expansion will include an endoscopy suite for GI procedures, Chron reports. - 4/5/18 -
The potential to be 1st — Dr. William Chey on Ritter Pharmaceuticals' lactose intolerance treatment
Becker's ASC Review spoke with William Chey, MD, of Ritter Pharmaceuticals' medical advisory board, about the first treatment for lactose intolerance, the company's RP-G28. The treatment has not yet received FDA approval. - 4/4/18